AI Summary
This study examines the use of genetic testing for homologous recombination repair mutations in men with metastatic castration-resistant prostate cancer (mCRPC). It aims to identify characteristics associated with this testing in order to better understand its role in this population. The findings could have implications for personalized treatment approaches and outcomes for men with mCRPC.
This cross-sectional study assesses homologous recombination repair mutation genetic testing and associated characteristics among men with metastatic castration-resistant prostate cancer (mCRPC).